Evidence map›Paper›PMID 30341219›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Pervasive tertiary structure in the dengue virus RNA genome.

Elizabeth A Dethoff, Mark A Boerneke, Nandan S Gokhale, Brejnev M Muhire, Darren P Martin, Matthew T Sacco, Michael J McFadden, Jules B Weinstein, William B Messer, Stacy M Horner and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 116 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. "Fertile" Mutations in SARS-CoV-2 RNA More Frequently Occurred in Hairpin Loops That Determine Virus Evolution.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Elizabeth A DethoffDepartment of Chemistry, University of North Carolina, Chapel Hill, NC 27599.
Mark A BoernekeDepartment of Chemistry, University of North Carolina, Chapel Hill, NC 27599.ORCID 0000-0003-0092-3203
Nandan S GokhaleDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710.
Brejnev M MuhireInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, 7000 Cape Town, South Africa.
Darren P MartinInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, 7000 Cape Town, South Africa.
Matthew T SaccoDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710.
Michael J McFaddenDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710.
Jules B WeinsteinDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR 97239.
William B MesserDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR 97239 weeks@unc.edu stacy.horner@duke.edu messer@ohsu.edu.
Stacy M HornerDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710; weeks@unc.edu stacy.horner@duke.edu messer@ohsu.edu.
Kevin M WeeksDepartment of Chemistry, University of North Carolina, Chapel Hill, NC 27599; weeks@unc.edu stacy.horner@duke.edu messer@ohsu.edu.ORCID 0000-0002-6748-9985
Duke Medical Center · USUniversity of North Carolina at Chapel Hill · USOregon Health & Science University · USUniversity of Cape Town · ZA

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Yessinia autotransporters (Yaps): Structure, function, and host responseU54AI057157 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SEMPOWSKI, GREGORY D · 2003 to 2013
$91.4M
Integrated Training in Cancer Model SystemsT32CA009156 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DER, CHANNING J. · 1985 to 2020
$19.7M
Viral Oncology Training GrantT32CA009111 · NCI · DUKE UNIVERSITY · PI LUFTIG, MICAH A. · 1985 to 2023
$8.9M
Discovery and Function of Higher-Order RNA StructureR35GM122532 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Kevin M Weeks · 2017 to 2026
$5.7M
Defining the role of the RNA modification N6-methyladenosine in the hepatitis C virus lifecycleR01AI125416 · NIAID · DUKE UNIVERSITY · PI Stacy Michelle Horner · 2016 to 2026
$5.5M
Mapping the RNA modification N6-methyladenosine during Zika virus infectionR21AI129851 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI HORNER, STACY MICHELLE, MASON, CHRISTOPHER EDWARD · 2017 to 2018
$469k
An RNA-targeted platform for anti-flavivirus drug discoveryR43AI129095 · NIAID · RIBOMETRIX, LLC · PI WARNER, KATHERINE DEIGAN · 2017 to 2017
$224k
The role of higher order RNA structure in RNA virus replication and infectionF32GM128330 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BOERNEKE, MARK A · 2018 to 2019
$120k
RNA Structure-Function Relationships in a Dengue Virus GenomeF32GM103180 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DETHOFF, ELIZABETH ANN · 2012 to 2013
$101k
NCI NIH HHS P30 CA016086NCI NIH HHS T32 CA009111NCI NIH HHS T32 CA009156NIAID NIH HHS R01 AI125416NIAID NIH HHS R21 AI129851NIAID NIH HHS R43 AI129095NIAID NIH HHS U54 AI057157NIGMS NIH HHS F32 GM103180NIGMS NIH HHS F32 GM128330NIGMS NIH HHS R35 GM122532
6 · The paper itself

Abstract

RNA virus genomes are efficient and compact carriers of biological information, encoding information required for replication both in their primary sequences and in higher-order RNA structures. However, the ubiquity of RNA elements with higher-order folds-in which helices pack together to form complex 3D structures-and the extent to which these elements affect viral fitness are largely unknown. Here we used single-molecule correlated chemical probing to define secondary and tertiary structures across the RNA genome of dengue virus serotype 2 (DENV2). Higher-order RNA structures are pervasive and involve more than one-third of nucleotides in the DENV2 genomic RNA. These 3D structures promote a compact overall architecture and contribute to viral fitness. Disrupting RNA regions with higher-order structures leads to stable, nonreverting mutants and could guide the development of vaccines based on attenuated RNA viruses. The existence of extensive regions of functional RNA elements with tertiary folds in viral RNAs, and likely many other messenger and noncoding RNAs, means that there are significant regions with pocket-containing surfaces that may serve as novel RNA-directed drug targets.

Indexed as

Genome, ViralBase PairingCapsidDengue VirusGenetic FitnessModels, MolecularNucleic Acid ConformationRNA, ViralSerogroupVirus AssemblyRNA, Viralgenome circularizationRING-MaPRNA tertiary structureviral packaging

Identifiers

PMID30341219
PMCPMC6233125
OpenAlexW2897004267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.